This is the library for the enduring materials from the Targets in Cancer IO: A Deep Dive, Recombinant Interleukin-18 Immunotherapy webinar that took place on July 18, 2022.
Targets for Cancer IO: A Deep Dive Series is supported, in part, by educational grants from Genmab, US, Inc. and Merck & Co., Inc. (as of 6/6/2022).
Meeting: 2022 Targets for Cancer IO: A Deep Dive, Recombinant Interleukin-18 Immunotherapy; Presenter: Scott W. Canna, MD - University of Pennsylvania, The Children's Hospital of Philadelphia; Date: July 18, 202200:30:24
Meeting: 2022 Targets for Cancer IO: A Deep Dive, Recombinant Interleukin-18 Immunotherapy; Presenter: Simone A. Minnie, PhD - Fred Hutchinson Cancer Research Center; Date: July 18, 202200:27:14
Meeting: 2022 Targets for Cancer IO: A Deep Dive, Recombinant Interleukin-18 Immunotherapy; Presenter: Aaron M. Ring, MD, PhD – Yale University School of Medicine; Date: July 18, 202200:25:01
Meeting: 2022 Targets for Cancer IO: A Deep Dive, Recombinant Interleukin-18 Immunotherapy; Presenter: Michael T. Lotze, MD, FACS – Nurix Therapeutics; Date: July 18, 202200:22:24
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us